-
-
Dr. Timothy Hatlen Contributes to Positive Phase 3 Hepatitis C Trial Results
A clinical research team led by Timothy Hatlen, MD, investigator in the Infectious Diseases and Immunology Innovation Hub at The Lundquist Institute, contributed to a major…
Research -
-
-
-
The Greatest Threat of Rheumatoid Arthritis May Not Come From the Joints, But the Heart
Physicians have increasingly recognized the connection between rheumatoid arthritis (RA) and cardiovascular disease. RA is characterized by systemic immune system activation and high-grade inflammation. In a…
Research -
Could the Nervous System Hold the Key to Better Asthma Treatments?
Asthma affects millions of people across the United States, making everyday activities like exercising, laughing, or even taking a deep breath difficult. Although treatments can help…
Research -
The Uppuluri Laboratory Receives NIH R21 Funding to Advance Research on Catheter-Associated Fungal Biofilms
The National Institutes of Health (NIH) has awarded an R21 grant titled “Regulation of Candida albicans Central Venous Catheter Biofilms by Transcription Factor Networks” to Priya Uppuluri, PhD, investigator…
Research -
Advancements in Lung Sensing Research Lead to New Priorities for Experts Across Disciplines
Nicholas Jendzjowsky, PhD, an investigator at The Lundquist Institute for Biomedical Innovation, along with collaborators across the country, spearheaded the National Heart, Lung, and Blood Institute…
Research -
Fighting Drug-Resistant Fungi: NIH Funds Innovative Antifungal Research at The Lundquist Institute
The Lundquist Institute for Biomedical Innovation received new funding from the National Institutes of Health (NIH) to advance cutting-edge research targeting life-threatening fungal infections. Led by…
Research